KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Free Cash Flow (2017 - 2025)

Guardant Health's Free Cash Flow history spans 9 years, with the latest figure at -$10.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 80.76% year-over-year to -$10.0 million; the TTM value through Dec 2025 reached -$188.9 million, up 22.49%, while the annual FY2025 figure was -$188.9 million, 22.49% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$10.0 million at Guardant Health, up from -$45.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$10.0 million in Q4 2025 and bottomed at -$109.1 million in Q2 2022.
  • The 5-year median for Free Cash Flow is -$68.7 million (2022), against an average of -$69.0 million.
  • The largest annual shift saw Free Cash Flow plummeted 1482.33% in 2021 before it surged 80.76% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$101.6 million in 2021, then grew by 11.3% to -$90.1 million in 2022, then rose by 8.12% to -$82.8 million in 2023, then soared by 37.07% to -$52.1 million in 2024, then soared by 80.76% to -$10.0 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Free Cash Flow are -$10.0 million (Q4 2025), -$45.8 million (Q3 2025), and -$65.9 million (Q2 2025).